Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy

Sakin A., SAHIN S., YASAR N., DEMIR C., ARICI S., GEREDELI C., ...Daha Fazla

LUNG CANCER, cilt.133, ss.38-44, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 133
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.lungcan.2019.05.007
  • Dergi Adı: LUNG CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.38-44
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Purpose: To investigate the prognostic effects of Allogeneic Blood Transfusion (ABT) in patients with metastatic Non-Small Cell Lung Cancer (NSCLC) receiving Chemotherapy (CT) in the first-line treatment, comparing untransfused patients to those receiving blood transfusion during treatment period or before treatment period.